'Institutional review board' diaporamas de présentation

GOOD CLINICAL PRACTICES WORKING GROUP

947 views • 59 slides

Use of Advance Directives in the Mental Health Context and Treatment Over Protest

Use of Advance Directives in the Mental Health Context and Treatment Over Protest. Karen A. DeSousa Office of the Attorney General. Advance Directives HB 2396(Bell)/SB 1142(Whipple).

802 views • 42 slides

DOMINICAN UNIVERSITY

563 views • 38 slides

The Institutional Review Board

The Institutional Review Board. Monica B. Spaulding, M.D. Chair-Health Sciences IRB Professor of Medicine. Outline. What is an IRB? Why does it exist What do we do IRB Reviews Full Expedited HIPAA Its impact on your research. What is an Institutional Review Board?.

561 views • 31 slides

Minority Recruitment and Adherence in Clinical Trials

Minority Recruitment and Adherence in Clinical Trials. Doris Browne, MD, MPH Program Director Breast and Gynecologic Cancer Research Group Division of Cancer Prevention National Cancer Institute. What Are Cancer Clinical Trials?. Research studies involving people

750 views • 26 slides

Pieces of the Puzzle

478 views • 26 slides

Airway Pressure Release Ventilation

Airway Pressure Release Ventilation. APRV review and indications in paediatrics. APRV. Terminology How it works Indications Advantages/disadvantages Review of paediatric studies Set-up (paed specific) Weaning Discussion. APRV.

604 views • 25 slides

Developing Effective Surveys

484 views • 23 slides

INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL

INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL. Sheree Miller, Pharm.D. University of Washington Medical Center 1-13-04. What is an Investigational Drug. new drugs old drugs- new indications, new combinations, new components investigational use of commercially available drugs.

232 views • 20 slides

CHAPTER OVERVIEW

CHAPTER OVERVIEW. The Format of a Research Proposal Being Neat Evaluating the Studies You Read Planning the Actual Research. THE FORMAT OF A RESEARCH PROPOSAL. Introduction A (brief) review of the relevant literature Method Proposed analysis of the data Results of the data

286 views • 17 slides

The Usage of Maps in Facilitating Conversations with Stakeholders about Educational Desegregation in Hartford

The Usage of Maps in Facilitating Conversations with Stakeholders about Educational Desegregation in Hartford. Brittany Price December 18, 2009 Educational Studies. Literature Review. Waterville Elementary School, Washington Invasive toad population Working with farmers in community

358 views • 17 slides

IND Case Studies

IND Case Studies. Deborah Lavoie, J.D., RAC Branch Chief, Regulatory Management Staff Office of Cellular, Tissue, and Gene Therapies Center for Biologics Evaluation and Research FDA. The Good IND. Sponsor had a pre-IND telecon prior to submitting IND. Sponsor asked specific questions.

383 views • 15 slides

Clinical Trials

Clinical Trials. The Way We Make Progress Against Disease. What Are Clinical Trials?. Research studies to find better ways to prevent, detect, or treat disease Help health care providers find ways to improve patient care. Why Are Clinical Trials Important?.

617 views • 15 slides

Informed Consent

Informed Consent. Basic and Additional Elements. Who must obtain consent?.

366 views • 15 slides

Ethics in Psychological Research

1.12k views • 15 slides

357 views • 14 slides

Ethics People should be treated as ends not means

Ethics People should be treated as ends not means. Ethical Responsibilities in Research Ethics in Steps. How are participants selected? Is there any bias in the way the participants were selected? Do the participants understand their participation is voluntary?

528 views • 13 slides

Chapter 13: An evaluation framework

Chapter 13: An evaluation framework. The aims are:. To discuss the conceptual, practical and ethical issues involved in evaluation. To introduce and explain the DECIDE framework. DECIDE: a framework to guide evaluation. Determine the goals . Explore the questions .

291 views • 11 slides

363 views • 10 slides

21 CFR 50.24

21 CFR 50.24. Toby A. Silverman, M.D. Branch Chief, Clinical Review Branch Division of Hematology, Office of Blood December 14, 2006. 21 CFR 312. Regulations governing conduct of investigations with investigational new drugs

425 views • 7 slides